atomoxetine hydrochloride has been researched along with Schizophrenia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, X; Li, W; Pan, L | 1 |
| Horder, J; Matthews, PRL; Pearce, M | 1 |
| Carvalho, AF; Correll, CU; de Bartolomeis, A; Fornaro, M; Köhler, CA; Solmi, M; Stubbs, B; Toyoshima, K; Veronese, N | 1 |
| Huemer, J; Sibitz, I | 1 |
| Creeden, C; George, TP; Reutenauer, EL; Sacco, KA; Vessicchio, JC; Weinberger, AH | 1 |
| Ball, MP; Boggs, DL; Buchanan, RW; Conley, RR; Dickinson, D; Feldman, S; Gold, JM; Kelly, DL; Liu, F; McMahon, RP; Nelson, M | 1 |
| Ball, MP; Buchanan, RW; Feldman, S; Kelly, DL; McMahon, RP; Warren, KR | 1 |
| Gangadhar, BN; Rao, MG; Raveendranathan, D; Varambally, S; Venkatasubramanian, G | 1 |
| Friedman, JI; Gorman, JM; Stewart, DG | 1 |
| Gangadhar, BN; Rao, NP; Venkatasubramanian, G | 1 |
| Bowler, S; Carpenter, D; Elbaz, Z; Fan, J; Flanagan, L; Friedman, JI; Harvey, PD; Lu, J; Parrella, M; Tang, CY; White, L | 1 |
4 review(s) available for atomoxetine hydrochloride and Schizophrenia
| Article | Year |
|---|---|
Meta-analysis on the efficacy of the norepinephrine reuptake inhibitors reboxetine and atomoxetine for the treatment of schizophrenia and attention deficit hyperactivity disorder.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Humans; Norepinephrine; Reboxetine; Schizophrenia; Treatment Outcome | 2023 |
Selective noradrenaline reuptake inhibitors for schizophrenia.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Citalopram; Cognition; Humans; Morpholines; Quality of Life; Randomized Controlled Trials as Topic; Reboxetine; Schizophrenia; Serotonin and Noradrenaline Reuptake Inhibitors; Viloxazine | 2018 |
Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with schizophrenia or schizoaffective disorder.
Topics: Amphetamines; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention; Executive Function; Humans; Memory, Short-Term; Methylphenidate; Problem Solving; Psychotic Disorders; Schizophrenia | 2019 |
Potential noradrenergic targets for cognitive enhancement in schizophrenia.
Topics: Adrenergic alpha-Agonists; Atomoxetine Hydrochloride; Cognition Disorders; Guanfacine; Humans; Norepinephrine; Prefrontal Cortex; Propylamines; Schizophrenia | 2004 |
4 trial(s) available for atomoxetine hydrochloride and Schizophrenia
| Article | Year |
|---|---|
Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Cognition Disorders; Dopamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Neuropsychological Tests; Norepinephrine; Prefrontal Cortex; Propylamines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation | 2009 |
A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia.
Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Atomoxetine Hydrochloride; Brief Psychiatric Rating Scale; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Propylamines; Schizophrenia; Severity of Illness Index | 2009 |
Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine.
Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Appetite Depressants; Atomoxetine Hydrochloride; Attention; Benzodiazepines; Body Mass Index; Body Weight; Brief Psychiatric Rating Scale; Clozapine; Combined Modality Therapy; Diet, Reducing; Double-Blind Method; Exercise; Female; Humans; Life Style; Male; Maryland; Middle Aged; Neuropsychological Tests; Obesity; Olanzapine; Propylamines; Psychotic Disorders; Schizophrenia | 2011 |
A pilot study of adjunctive atomoxetine treatment to second-generation antipsychotics for cognitive impairment in schizophrenia.
Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Atomoxetine Hydrochloride; Cognition Disorders; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Magnetic Resonance Imaging; Pilot Projects; Propylamines; Schizophrenia; Schizophrenic Psychology | 2008 |
3 other study(ies) available for atomoxetine hydrochloride and Schizophrenia
| Article | Year |
|---|---|
Detecting and treating adult attention deficit hyperactivity disorder in a patient with schizophrenia.
Topics: Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Comorbidity; Day Care, Medical; Drug Therapy, Combination; Humans; Male; Patient Admission; Personality Assessment; Propylamines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Young Adult | 2014 |
Atomoxetine-induced vocal tics in a patient with schizophrenia.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Humans; Male; Olanzapine; Propylamines; Schizophrenia; Tics | 2012 |
Treatment of cognitive deficits in schizophrenia with atomoxetine: a case report.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Cognition Disorders; Female; Humans; Propylamines; Schizophrenia; Treatment Outcome | 2007 |